FI940425A - Modifioidut oligodeoksiribonukleotidit, niiden valmistus ja niiden terapeuttinen käyttö - Google Patents

Modifioidut oligodeoksiribonukleotidit, niiden valmistus ja niiden terapeuttinen käyttö Download PDF

Info

Publication number
FI940425A
FI940425A FI940425A FI940425A FI940425A FI 940425 A FI940425 A FI 940425A FI 940425 A FI940425 A FI 940425A FI 940425 A FI940425 A FI 940425A FI 940425 A FI940425 A FI 940425A
Authority
FI
Finland
Prior art keywords
compounds
groups
sulfur
oxygen
preparation
Prior art date
Application number
FI940425A
Other languages
English (en)
Swedish (sv)
Other versions
FI111265B (fi
FI940425A0 (fi
Inventor
Hidehiko Furukawa
Kenji Momota
Hitoshi Hotoda
Makoto Koizumi
Masakatsu Kaneko
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of FI940425A0 publication Critical patent/FI940425A0/fi
Publication of FI940425A publication Critical patent/FI940425A/fi
Application granted granted Critical
Publication of FI111265B publication Critical patent/FI111265B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base
    • C12N2310/336—Modified G
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI940425A 1993-01-29 1994-01-28 Menetelmä lääkeaineina käyttökelpoisten modifioitujen oligodeoksiribonukleotidien valmistamiseksi ja niiden välituotteita FI111265B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP1350993 1993-01-29
JP1350993 1993-01-29
JP13557393 1993-06-07
JP13557393 1993-06-07
JP13851793 1993-06-10
JP13851793 1993-06-10

Publications (3)

Publication Number Publication Date
FI940425A0 FI940425A0 (fi) 1994-01-28
FI940425A true FI940425A (fi) 1994-11-04
FI111265B FI111265B (fi) 2003-06-30

Family

ID=27280283

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940425A FI111265B (fi) 1993-01-29 1994-01-28 Menetelmä lääkeaineina käyttökelpoisten modifioitujen oligodeoksiribonukleotidien valmistamiseksi ja niiden välituotteita

Country Status (19)

Country Link
US (2) US5674856A (fi)
EP (1) EP0611075B1 (fi)
KR (1) KR100318796B1 (fi)
CN (2) CN1039014C (fi)
AT (1) ATE146479T1 (fi)
AU (1) AU670154B2 (fi)
CA (1) CA2114355A1 (fi)
CZ (1) CZ287050B6 (fi)
DE (1) DE69401136T2 (fi)
DK (1) DK0611075T3 (fi)
ES (1) ES2098866T3 (fi)
FI (1) FI111265B (fi)
GR (1) GR3022821T3 (fi)
HK (2) HK1000191A1 (fi)
HU (1) HU222834B1 (fi)
IL (1) IL108467A (fi)
NO (1) NO309427B1 (fi)
NZ (2) NZ250795A (fi)
RU (1) RU2111971C1 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2114355A1 (en) * 1993-01-29 1994-07-30 Hidehiko Furukawa Modified oligodeoxyribonucleotides, their preparation and their therapeutic use
US6291438B1 (en) 1993-02-24 2001-09-18 Jui H. Wang Antiviral anticancer poly-substituted phenyl derivatized oligoribonucleotides and methods for their use
CN1060177C (zh) * 1997-06-28 2001-01-03 中国科学院上海生物化学研究所 3′－单磷酸化寡核苷酸
GB9823646D0 (en) 1997-12-19 1998-12-23 Brax Genomics Ltd Compounds for mass spectrometry
US6995259B1 (en) 1998-10-23 2006-02-07 Sirna Therapeutics, Inc. Method for the chemical synthesis of oligonucleotides
DE10041809A1 (de) * 2000-08-25 2002-03-07 Giesing Michael Arrays immobilisierter Biomoleküle, deren Herstellung und Verwendung
US7205399B1 (en) 2001-07-06 2007-04-17 Sirna Therapeutics, Inc. Methods and reagents for oligonucleotide synthesis
US9394167B2 (en) 2005-04-15 2016-07-19 Customarray, Inc. Neutralization and containment of redox species produced by circumferential electrodes
US20070065877A1 (en) * 2005-09-19 2007-03-22 Combimatrix Corporation Microarray having a base cleavable succinate linker
WO2011071078A1 (ja) * 2009-12-08 2011-06-16 国立大学法人岐阜大学 芳香族化合物、並びに、それを用いたオリゴヌクレオチド誘導体合成用修飾担体、オリゴヌクレオチド誘導体及びオリゴヌクレオチド構築物
CN102766183B (zh) * 2011-05-05 2016-09-14 中国人民解放军军事医学科学院毒物药物研究所 具有抗hiv-1融合活性的修饰的核酸结构
CN116496335B (zh) * 2023-03-21 2024-03-08 中国药科大学 一种修饰核苷酸及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0173356B1 (en) * 1980-02-29 1990-09-19 University Patents, Inc. Process for preparing modified inorganic polymers
US4849513A (en) * 1983-12-20 1989-07-18 California Institute Of Technology Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for the preparation of oligonucleotides containing aliphatic amino groups
FR2568254B1 (fr) * 1984-07-25 1988-04-29 Centre Nat Rech Scient Application d'oligonucleotides lies a un agent intercalant, notamment a titre de medicament
US5252760A (en) * 1985-03-28 1993-10-12 Chiron Corporation Method of using colored phosphorylating reagents
DE3751468T2 (de) * 1986-10-30 1996-02-29 Daicel Chem Verfahren zur herstellung von oligonukleotiden und verbindungen zur bildung hochmolekularer schutzgruppen.
ATE87932T1 (de) * 1986-12-02 1993-04-15 Centre Nat Rech Scient Alpha-oligonukleotide.
US5276019A (en) * 1987-03-25 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products
US4904582A (en) * 1987-06-11 1990-02-27 Synthetic Genetics Novel amphiphilic nucleic acid conjugates
WO1990012022A1 (en) * 1989-03-31 1990-10-18 University Patents, Inc. Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections
KR930702374A (ko) * 1990-11-20 1993-09-08 가와무라 요시부미 안티 센스 핵산 유도체
US5672697A (en) * 1991-02-08 1997-09-30 Gilead Sciences, Inc. Nucleoside 5'-methylene phosphonates
US5220003A (en) * 1991-03-29 1993-06-15 The Regents Of The University Of California Process for the synthesis of 2',3'-dideoxynucleosides
JP3061659B2 (ja) * 1991-08-01 2000-07-10 ヤマサ醤油株式会社 ２−｛２−（モノメトキシトリチルオキシ）エチルチオ｝エチル基および該基の使用法
US5646261A (en) * 1992-01-22 1997-07-08 Hoechst Aktiengesellschaft 3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and use
IL104461A (en) * 1992-01-22 2001-05-20 Hoechst Ag Analogs of oligonucleotide, their preparation and pharmaceutical preparations containing them
CA2114355A1 (en) * 1993-01-29 1994-07-30 Hidehiko Furukawa Modified oligodeoxyribonucleotides, their preparation and their therapeutic use
JPH09208729A (ja) * 1996-02-02 1997-08-12 Sekisui Chem Co Ltd 帯電防止プラスチックプレートもしくはシートの製造方法

Also Published As

Publication number Publication date
IL108467A (en) 1999-09-22
HK1016151A1 (en) 1999-10-29
DE69401136D1 (de) 1997-01-30
US5807837A (en) 1998-09-15
US5674856A (en) 1997-10-07
CN1098107A (zh) 1995-02-01
EP0611075A1 (en) 1994-08-17
NZ250795A (en) 1997-04-24
KR940018394A (ko) 1994-08-16
NO940310D0 (no) 1994-01-28
CN1193013A (zh) 1998-09-16
DE69401136T2 (de) 1997-07-10
IL108467A0 (en) 1994-04-12
HUT66266A (en) 1994-10-28
ES2098866T3 (es) 1997-05-01
KR100318796B1 (ko) 2002-06-20
HK1000191A1 (en) 1998-01-27
RU2111971C1 (ru) 1998-05-27
FI111265B (fi) 2003-06-30
NO309427B1 (no) 2001-01-29
NZ280616A (en) 1997-04-24
AU670154B2 (en) 1996-07-04
AU5473194A (en) 1994-08-04
DK0611075T3 (da) 1997-07-07
CA2114355A1 (en) 1994-07-30
GR3022821T3 (en) 1997-06-30
NO940310L (no) 1994-08-01
EP0611075B1 (en) 1996-12-18
CZ19094A3 (en) 1994-12-15
HU222834B1 (hu) 2003-11-28
FI940425A0 (fi) 1994-01-28
CN1065238C (zh) 2001-05-02
HU9400246D0 (en) 1994-05-30
CN1039014C (zh) 1998-07-08
ATE146479T1 (de) 1997-01-15
CZ287050B6 (en) 2000-08-16

Similar Documents

Publication Publication Date Title
ATE282614T1 (de) Phenylharnstoff und phenylthioharnstoffderivate
ATE247654T1 (de) Neue heterozyklische verbindungen
LU91196I2 (fr) Picoxystrobin et ses dérivlés pharmaceutiquement acceptables(ACANTO).
DE3781716D1 (de) Mittel zur ortsspezifischen alkylierung.
DE69120581D1 (de) 1,8-Naphthyridin-2-on-Derivate
DK202388D0 (da) Hidtil ukendte forbindelser
FI892497A0 (fi) Menetelmä terapeuttisesti aktiivisten bentsamidijohdannaisten valmistamiseksi
FI940425A (fi) Modifioidut oligodeoksiribonukleotidit, niiden valmistus ja niiden terapeuttinen käyttö
DE69522703T2 (de) Aminotetrazol-derivate verwendbar als stickstoff-oxid-synthase inhibitoren
DE68908737D1 (de) Imidazol-Verbindungen und diese enthaltende Textilbehandlungs-Zusammenstellungen.
FI881104A (fi) Menetelmä antidiabeettisina aineina käytettävien bentsoksatsiinijohdannaisten valmistamiseksi
IT1232956B (it) Ammino derivati perossicarbossilici
ATE137759T1 (de) S'-adenosyl-methionin-decarboxylase-inhibitoren
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
ATE205209T1 (de) Chinolincarbonsäurederivate und ihre salze
ATE133677T1 (de) Bisphosphonsäurederivate, ihre produktion und ihre verwendung
DE69016266D1 (de) Aminoketonverbindungen.
ES2055094T3 (es) Utilizacion de poliaminas oxidadas, en particular nn'-bis-(3-propionaldehido)-1-4-diaminobutano (dialdehido espermina) como agentes inmunosupresores.
EA200200462A1 (ru) Производные 2-арилхинолина, их получение и терапевтическое применение
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.